Exactly my point. I think the strategy of getting into the VA hospitals first is pretty smart. Took maybe longer to get off the ground but the entire VA system is now a case study to show the private sector. This should soar. Now I know Joe didn’t throw out the 9B number so I take that with a grain of salt. That assumes all patients get treated with this product and no other and also assumes full retail price, no discounts. I’d be happy with .5B over the next 12 months. Ramping up from there to 3 or 4 B in 24-36 months. Yea I’d be ok with that.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links